Speaker Profile
Dr. Alexandra LaStella
Dr. Alexandra LaStella is a licensed Doctor of Pharmacy and the founder of WritePharma, the nation’s leading pharmacist-exclusive medical writing agency. A graduate of St. John’s University, Dr. LaStella completed advanced pharmacy practice experiences in psychiatric care, infectious disease, HIV/AIDS treatment, and nonsterile compounding—areas that continue to influence her clinical interests and editorial direction.
After witnessing firsthand how underutilized pharmacists are in the broader healthcare communication space, she founded WritePharma with a clear purpose: to create high-quality, pharmacist-led content that supports providers, educates the public, and advances evidence-based practice. Since its inception, WritePharma has grown into a respected agency serving clients in the pharmaceutical, nutraceutical, and cosmeceutical industries, while also producing two of its own publications: the WritePharma Drug Information Blog and the peer-reviewed journal Scriptum Pharmacologia.
Beyond her passion for research and writing, Alexandra is deeply committed to supporting the professional growth and well-being of other pharmacists. Through flexible, paid medical writing opportunities, she has created a space where PharmDs can grow their clinical and communication skills—outside the rigid structure of traditional pharmacy. This mission is personal: to help pharmacists rediscover purpose, balance, and joy in their work.
Alexandra leads with a core belief in authenticity, respect, balance, and support—for the data, for the literature, and for each other. Through her work, she continues to challenge the limits of what pharmacists can do, one project at a time.

Dr. Alexandra Lastella
June 18 2025
01 : 00 PM EST
60 Minutes
Decoding Drug Data: Understanding Clinical Biostatistics in Pharmacy Practice
Clinical biostatistics is the backbone of interpreting drug studies and delivering evidence-based care in pharmacy practice. Pharmacists and healthcare providers are constantly exposed to clinical trial data—from journal articles and guideline updates to drug monographs and formulary reviews. Yet for many, the statistical components remain a source of confusion or hesitation. Without a firm grasp of key val..